https://www.avient.com/resource-center/knowledge-base/article/polyketone-next-generation-sustainable-nylon-alternative?rtype%5B0%5D=1164
In this webinar, our technical experts unpack how PK can reduce carbon emissions, deliver exceptional performance, and help overcome concerns or challenges.
https://www.avient.com/resource-center/knowledge-base/article/polyketone-next-generation-sustainable-nylon-alternative
In this webinar, our technical experts unpack how PK can reduce carbon emissions, deliver exceptional performance, and help overcome concerns or challenges.
https://www.avient.com/resource-center/knowledge-base/article/new-horizons-fiber-optic-cable
IT, telecom, defense, aerospace, BFSI (banking, financial services, and insurance), and other “end-user verticals” are increasingly relying on these cables to deliver information, keep people safe and healthy, and grow economies¹.
https://www.avient.com/sites/default/files/2025-03/Q4 2024 Avient Webcast Slides w Non-GAAP.pdf
FX • Driven by strong drug delivery sales, new business wins in building & construction and consumer • Higher sales and favorable mix more than offset by variable compensation reset resulting in lower adjusted EBITDA Copyright © .
EBITDA 358 384 FY 2023 FY 2024 • Driven by new applications for drug delivery and building & construction as well as demand recovery in packaging and consumer • Adjusted EBITDA margin expansion driven by higher sales and net price benefit EXCL.
https://www.avient.com/resource-center?document_type=59&all=1
A custom, impact-modified Trilliant™ HC formulation plus technical services met key needs and accelerated commercialization for a drug delivery device
Closed System Drug Transfer Device
Custom Versalloy™ HC 9220-90 formulation provides regulatory compliance for drug transfer device
https://www.avient.com/investor-center/news/avient-provides-third-quarter-2020-performance-update
We are seeing a recovery in demand in the third quarter, and expect to deliver adjusted EPS of approximately
As a result, we expect the Specialty Engineered Materials segment will deliver over 15% EBITDA growth versus the prior year third quarter."
of free cash flow during the quarter and is on-track to deliver
https://www.avient.com/products/engineered-polymer-formulations/general-engineered-formulations/nymax/bergamid-polyamide-formulations
Delivered a high-impact nylon formulation with equal performance and 80% less weight
Nymax™ nylon substrate and Versaflex™ TPE overmold combine to deliver structural integrity and comfort for archery OEM
Nymax™ Glass and Mineral Fiber Reinforced Nylon 6 Formulation delivers service and performance for transportation OEM
https://www.avient.com/products/thermoplastic-elastomers/onflex-thermoplastic-elastomers
Formulated for high temperature applications and delivering long-term sealing performance.
OnFlex™ AF TPE delivered global solution for a cup holder mat with excellent low VOC/FOG properties and high-quality, low gloss surface finish
Delivering thermoplastic elastomer solutions for automotive applications.
https://www.avient.com/resource-center?document_type=59&document_subtype=127&industry=0&product_family=1688&product_subfamily=0&product_name=0&op=FILTER RESULTS&form_build_id=form-eABbCwp28m0LYQS3A8tRxIzSVnbqlh1x6IrU-oy_f-k&form_id=resource_filter_form
Complēt™ LGF, moisture-resistant grade delivers improved performance and cost savings for aftermarket parts manufacturer
Complēt™ LCF PES formulation delivered lightweighting for an aerospace seat component through metal replacement (replacing aluminum)
Injection molded Complēt™ long carbon fiber reinforced nylon composite delivered high stiffness and low weight while simplifying manufacturing
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Colorants and Formulations Special Effects Application Bulletin_0.pdf
KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal-derived substances • Available as pre-colored formulation or concentrate and for use in different polymers REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) and/or Device Master File • Food contact established with FDA/EU** APPLICATION BULLETIN * Design note: Effect colors require careful consideration of part design and polymer flow paths to minimize visible flow lines.